Shift To Biosimilars, $5 Bn Nutraceutical Boom: India`s Pharma Sector Prepares For Next BIG Leap
From reducing reliance on Chinese APIs to expanding innovation in biologics and next-generation therapies like GLP-1 agonists for obesity and diabetes, the sector is moving beyond its generics-driven legacy into a future powered by scientific capability, self-reliance, and global market leadership.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
